Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WRL | Ann: Units on Issue Disclosure - September 2024 | 04/10/24 | 0 | 79 | |||
|
|||||||
WRL | Ann: Annual Report | 27/09/24 | 0 | 66 | |||
|
|||||||
WRL | Ann: Units on Issue Disclosure - August 2024 | 05/09/24 | 0 | 87 | |||
|
|||||||
WRL | Ann: Units on Issue Disclosure - July 2024 | 06/08/24 | 0 | 77 | |||
|
|||||||
WRL | Ann: Units on Issue Disclosure - June 2024 | 04/07/24 | 0 | 90 | |||
|
|||||||
WRL | Ann: Estimated Distribution Announcement | 27/06/24 | 0 | 98 | |||
|
|||||||
WRL | Ann: Distribution Timetable | 24/06/24 | 0 | 112 | |||
|
|||||||
WRL | Ann: Units on Issue Disclosure - May 2024 | 19:06 | 0 | 151 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |